Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, this FDA Warning Letter issued in August 2019 addresses Deva Holding AS - Cerkezkoy Subesi, a drug manufacturer or distributor. Without access to the full letter text or subject line, the specific regulatory violations cannot be determined from the available information. The warning falls under FDA's drug product oversight, though the issuing office is not specified in the metadata provided. Additional details would be needed to characterize the nature and scope of the compliance concerns.